5 min readCo-authored by Ryan McCartney Startups are seeking new sources of debt financing following the collapse of Silicon Valley’s biggest lender. The collapse of Silicon Valley Bank has spurred venture capital-funded growth companies to take a harder look than ever at their cash flows, burn rates, and how much runway they have to profitability. Many of…
3 min readAuthor’s Note Since compiling the data for our Q4 2022 debt market quarterly update, the market has faced unprecedented turmoil led by the collapse of Silicon Valley Bank. In order to provide consistent updates on the debt financing market, we are distributing our Q4 2022 report but also want to provide context on the current…
3 min readWelcome to Capital Advisors Group’s inaugural quarterly newsletter that will provide a snapshot of the current state of the debt financing markets. Capital Advisors Group has been advising innovative venture-backed and growth-stage companies on debt finance transactions for more than 18 years. This newsletter will provide insight into debt markets, specifically as they relate to…
6 min readAfter enjoying years of favorable borrowing conditions, emerging biotechnology growth companies are facing headwinds generated by the current disruption of global financial markets. Inflation is high, interest rates are on the rise and equity markets are sinking. Lenders have shifted to conservatism, setting the bar higher for borrowers who now must adjust to new realities….
5 min readCapital Advisors Group has written extensively in the past about the when and how a company can maximize the utility of venture debt financing, focusing on variables such as the company’s financial profile, its growth and development strategy, and management’s priorities. With this information in hand, Capital Advisors Group can help identify and engage the…
3 min readBiotech companies have taken center stage during the pandemic of 2020. Between the many vaccine initiatives and even more numerous investments in testing and new Covid-19 therapies, money is flooding into the sector at a record rate. Biotechs raised more than $6 billion in initial public offerings in just the first half of the year….
8 min readDOWNLOAD FULL REPORT Capital Advisors Group is a Boston-area based institutional investment advisor that has been helping venture-backed companies invest their cash assets for more than 22 years. Its debt finance consulting division helps venture-backed companies determine their optimum capital structures, identifies appropriate lenders, sources term sheets and negotiates deals. Executive Summary Capital Advisors Group’s…
2 min readJune 30th may be a day of reckoning for many early- and growth-stage companies with venture debt loan obligations. That’s a date when lenders schedule end-of-quarter “covenant testing” to ensure borrowers will continue to be able to make timely payments while using loans for their intended purposes. If you’ve taken on debt to extend your…
2 min readAt Capital Advisors Group, we have advised hundreds of early-stage companies on billions of dollars of debt transactions over the past 17 years. We’ve learned that every deal is different, and every company’s capital structure is unique. But one thing never seems to change: even the best-laid plans can go awry. Over the years, we…
7 min readDOWNLOAD FULL REPORT Introduction At Capital Advisors Group, we have advised hundreds of early-stage companies on billions of dollars of debt transactions over the past 17 years. You might think that we’ve seen it all—but we haven’t, not even close. Every deal is different, and every company’s capital structure is unique. However, there are some…